Tuesday, March 02, 2010

Commercial Compliance for Pharmaceutical and Medical Device Companies

Date Posted: 02/22/2010 
Size: 5.62MB 
Length: 00:12:17 
Thought Leader: Daniel Garen, Chief Compliance Officer and Senior Counsel, Siemens Healthcare Sector, USA

In an exclusive interview with PharmaVOICE, Mr. Garen shares his expertise and insights on a variety of commercial compliance issues, including The Sunshine Act, Healthcare Reform, the Foreign Corrupt Practices Act (FCPA), and how companies can create a culture of compliance through proactivity. Mr. Garen is also the keynote speaker at the upcoming Marcus Evans' Commercial Compliance for Pharmaceutical and Medical Device Companies Conference, April 12-13, Washington, D.C. For more information about the conference, please go to: http://www.marcusevansch.com/commericalcompliance.


For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Leveraging Digital Technology in Pharmaceutical Marketing: A New Agency Model

Date Posted: 01/19/2010
Size: 6.95MB
Length: 00:15:11
Thought Leaders: Kurt Holstein, Co-Founder and President, Rosetta, and Steven Michaelson, Founder and CEO, Wishbone

Mr. Holstein and Mr. Michaelson discuss the benefits and challenges of the new agency model that has emerged with the growth of digitally enabled communications.


For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.